ETF UNO / Portfolio Analyser Open the analyser →

Home › ETF database › XLV

XLV Health Care Select Sector SPDR Fund

XLV is a Healthcare ETF issued by State Street. It tracks the S&P 500 Health Care index, costs 0.12% a year, and launched in December 1998.

Composition and assets as of 2026-10-27.

Key facts

TickerXLV
Full nameHealth Care Select Sector SPDR Fund
IssuerState Street
CategoryHealthcare
Sub-categoryS&P Sector
Index trackedS&P 500 Health Care
Expense ratio0.12%
Assets under management$47.51bn
Inception22 December 1998
Asset classEquity
Geographic mandateUnited States (single country)

Sector allocation

Geographic mandate

This fund is chartered to hold companies domiciled in the United States. That is one country, so there is nothing to split: the mandate answers the question a percentage would have answered.

Top 10 holdings

  1. 1Eli Lilly and Co
  2. 2Johnson & Johnson
  3. 3AbbVie Inc
  4. 4Merck & Co Inc
  5. 5UnitedHealth Group Inc
  6. 6Thermo Fisher Scientific Inc
  7. 7Amgen Inc
  8. 8Gilead Sciences Inc
  9. 9Abbott Laboratories
  10. 10Pfizer Inc

Frequently asked

What is XLV's expense ratio?

Health Care Select Sector SPDR Fund charges 0.12% a year — $12 on a $10,000 holding.

What index does XLV track?

Health Care Select Sector SPDR Fund tracks the S&P 500 Health Care index.

How large is XLV?

Our dataset puts XLV at about $47.51bn in assets under management (as of 2026-10-27). Assets move with markets and flows, so treat this as a snapshot rather than a current figure.

What are XLV's largest holdings?

The 10 largest holdings in our dataset are Eli Lilly and Co, Johnson & Johnson, AbbVie Inc, Merck & Co Inc, UnitedHealth Group Inc, Thermo Fisher Scientific Inc, Amgen Inc, Gilead Sciences Inc, Abbott Laboratories and Pfizer Inc.

Where is XLV invested?

It is a single-country fund: the mandate is the United States, and the fund holds companies domiciled there.

Chosen from the same category where one exists, then from other equity funds in this database.